Insulin levels have been related to poor prognosis in breast cancer [24], and persistent hyperinsulinemia reduces levels of IGF Binding Protein 1 (IGFBP-1), thereby increasing the bioactive concentrations of IGF1 [25]. The gene discussed is IGFBP1; the disease is Hyperinsulinemia.